Abloid

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAbloid
Drug Alias NameAmyloid protein deposition inhibitor (Virionics)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVirionics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbGenesis IncVirionics
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A